9.18.06: Canadian Healthcare & Biotechnology Report
2 analysts and top management from 22 firms examine the Canadian Healthcare & Biotechnology sector in this 87 page report from The Wall Street Transcript.

  1. Large Cap Canadian Healthcare Companies: Joseph Walewicz, CIBC World Markets

  2. Canadian Healthcare & Life Sciences Companies: Shameze Rampertab, Jennings Capital

  3. Off the Record: Off the Record asks company leadership which management teams in their sector they most respect for their ability to execute and generate shareholder value.

  4. CEO Interviews (average 2,500 words): Top management from 22 sector firms examine the outlook for their firm and sector. Firms interviewed include: Adherex Technologies, Aeterna Zentaris, ARIUS Research, Atrium Biotechnologies, Axcan Pharma, ChondroGene Ltd., DRAXIS Health, Excel-Tech, Forbes Medi-Tech, Hythiam, Liponex, Medical Ventures, MedMira, MIGENIX, Neptune Technologies & Bioressources, Novadaq Technologies, Paladin Labs, Resverlogix Corp., SemBioSys Genetics, Swiss Medica, Theratechnologies and Victhom Human Bionics.

    Topics covered: Clinical laboratory businesses - Isotopes space - FDA review process - New advertising demographics - Growth hormones - Cancer treatments - Health care services companies - IPO expectations 

    Companies covered: Angiotech Pharmaceuticals (ANPI), CML Healthcare Income Fund (CLC_UN:TSX), CryoCath Technologies (CYT:TSX), Labopharm (DDSS), MDS Inc. (MDZ), Patheon (PTI:TSX), TLC Vision Corporation (TLCV), Boston Scientific (BSX), Vasogen (VSGN), Chemokine Therapeutics (CHKT), Theratechnologies (TH:TSX), Liponex (LPX:TSX) and Medisys Health Group (MHG_UN:TSX).
    ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us

    For immediate access online - click here to gain a password.  

    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
           		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

 

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.


Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE